BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Nosology
,
Bleomycin
,
rs3825942
,
PRKCA
,
calcium channel activity
,
Arthritis
,
Lymphocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
janus kinase inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
Epithelial cells from small airway treated with interferons, Baricitinib or Ruxolitinib
Ovarian cancer model treated with JAK inhibitor AZD1480
Skin biopsies of atopic dermatitis patients treated with oral dual JAK/SYK inhibitor ASN002
Lesional and non-lesional skin from Psoriasis patients treated with TYK2/JAK1 inhibitor PF06700841
Explore Curated Studies Results
Literature
Most Relevant Literature
In vitro JAK kinase activity and inhibition assays.
In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis.
JAK2 the future: therapeutic strategies for JAK-dependent malignancies.
Janus kinase inhibitors as a new therapeutic principle].
Profiling of dihydroorotate dehydrogenase, p38 and JAK inhibitors in the rat adjuvant-induced arthri…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis
Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoi…
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus
Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8…
Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Idiopathic Infl…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ